Canada In-Commerce List for Food & Drug Act Substances Services
Intertek’s scientific and regulatory experts help companies successfully complete Canada’s ICL substance nomination process.
Health Canada’s In-Commerce List (ICL) is an administrative list designed to assist the priorities and policies for protecting the health of Canadians and their environment until a full regulatory structure for Food and Drug Act regulated substances is in place.
The purpose of this initiative is to ensure that substances listed on the “current” ICL are correctly identified and verified by Health Canada. This updated list will be referred to as the “revised” ICL. Health Canada is encouraging stakeholders to participate in a collaborative effort to revise the ICL by making nominations of substances believed to meet the eligibility criteria. Once the government receives and verifies the information of a nomination, the nominated substance will be added to the revised list.
The nomination process is divided into Phase I and Phase II. Health Canada has announced the successful completion of Phase I of the Nominations Process for the revised ICL. Phase II of the nomination process is now open to all distributors, manufacturers and importers of eligible substances until February 14, 2012. Once Phase II has concluded, the revised ICL will be published in Canada Gazette.
Regardless of whether your substance appears on the current ICL, unless a nomination for the substance is received and accepted, it will not be added to the revised ICL. Failure to nominate your substance to the revised ICL will impact your ability to meet your business needs, as substances that are not present on the list are considered to be “new” substances and will be subject to notification.
Canada In-Commerce List for Food & Drug Act Substances Services
- Advise if a substance is eligible for addition or nomination to the ICL
- Review the data available to determine if there are any application deficiencies when adding a substance to the ICL or when nominating a substance to the revised ICL
- Prepare and submit applications to the regulating authority
- Negotiate with regulatory authorities to maintain confidential business information
- Work with you to respond to any questions or issues raised by EAU
- Monitor the Canada Gazette to ensure that the revised ICL includes eligible and/or nominated substance(s) of interest
Related Services
Request more information to see how Intertek can help your organization with Canada In-Commerce List for Food & Drug Act Substances Services.